Hemolytic Uremic Syndrome and Toxicant Exposure
Hemolytic uremic syndrome (HUS) is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury from endothelial damage and microvascular thrombosis. While HUS is primarily caused by Shiga toxin-producing E. coli, non-infectious causes—including toxicant exposures—can trigger the syndrome through direct vascular endothelial injury.
PFAS Vascular Endothelial Toxicity
PFAS compounds directly injure vascular endothelial cells through oxidative stress and mitochondrial dysfunction, creating the endothelial damage that initiates HUS-like microangiopathic cascades. At high acute exposures, PFAS-induced endothelial injury may be severe enough to trigger clinically apparent microangiopathic processes, though this connection is primarily established in animal models.
Chronic Subthreshold Effects
At typical environmental exposure levels, PFAS likely do not cause overt HUS. However, chronic low-level endothelial injury from environmental PFAS exposure may lower the threshold for HUS development when combined with other triggers—including infectious exposures, medications, or genetic predispositions to endothelial fragility.
Nephrology Awareness
Nephrologists evaluating atypical or recurrent HUS without infectious etiology should include environmental toxicant assessment in diagnostic workups. PFAS body burden testing may be informative in HUS patients with significant environmental exposure history, particularly where infectious and genetic causes have been excluded